IDYA - Company ID 0001676725
The table below shows IDEAYA Biosciences, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $112.83M | $84.38M | $157.02M | $68.63M | $92.05M | $72.04M |
| Short-term investments | $526.56M | $591.94M | $368.10M | $296.20M | $154.72M | $211.55M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $666.73M |
| $689.71M |
| $532.63M |
| $370.45M |
| $251.00M |
| $288.61M |
| Property, plant & equipment | $8.22M | $8.97M | $6.16M | $6.51M | $4.76M | $4.27M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $1.11B | $1.12B | $649.32M | $387.97M | $381.35M | $298.27M |
| Accounts payable | $17.58M | $15.42M | $6.60M | $4.28M | $2.10M | $953.00K |
| Total current liabilities | $58.81M | $46.07M | $27.10M | $31.72M | $45.16M | $38.64M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $86.39M | $64.94M | $28.23M | $38.51M | $79.83M | $100.00M |
| Retained earnings | -$736.54M | -$622.84M | -$348.36M | -$235.40M | -$176.75M | -$126.99M |
| Total equity | $1.02B | $1.06B | $621.09M | $349.45M | $301.51M | $198.27M |